

  <!doctype html>
<html lang="en-US">

<!-- Mirrored from www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/ by HTTrack Website Copier/3.x [XR&CO'2014], Tue, 04 Oct 2022 17:10:49 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=UTF-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1">
    <link rel="profile" href="https://gmpg.org/xfn/11">
    <link rel="preload" as="font" type="font/woff2" href="../../wp-content/themes/mhh-merck-mco-theme/fonts/InventionVF_W_Wght.woff2" crossorigin="anonymous">
<link rel="preload" as="font" type="font/woff2" href="../../wp-content/themes/mhh-merck-mco-theme/fonts/InventionVF_Italics_W_Wght.woff2" crossorigin="anonymous">    <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' />

	<!-- This site is optimized with the Yoast SEO plugin v18.2 - https://yoast.com/wordpress/plugins/seo/ -->
	<title>Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States - Merck.com</title>
	<link rel="canonical" href="index.html" />
	<meta property="og:locale" content="en_US" />
	<meta property="og:type" content="article" />
	<meta property="og:title" content="Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States - Merck.com" />
	<meta property="og:description" content="Merck Has Completed Manufacturing of 10 Million Courses of Therapy and Remains on Track to Produce at Least 20 Million Courses in 2022 to Provide Widespread Access to Molnupiravir Globally Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately 3.1 million courses of molnupiravir, an investigational oral antiviral COVID-19 medicine, have been provided to the U.S. government for allocation across the country. The U.S. Department of Health and Human Services (HHS) has created a public website to help providers identify locations that have received shipments of government-procured COVID-19 therapeutics available under Emergency Use Authorization. In 2021, Merck entered a procurement agreement with the U.S. government under which the company agreed to supply approximately 3.1 million courses of molnupiravir to the U.S. government upon Emergency Use Authorization or approval from the U.S. Food and" />
	<meta property="og:url" content="index.html" />
	<meta property="og:site_name" content="Merck.com" />
	<meta property="article:modified_time" content="2022-10-04T04:08:03+00:00" />
	<meta property="og:image" content="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20220208005551r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en" />
	<meta name="twitter:card" content="summary_large_image" />
	<meta name="twitter:label1" content="Est. reading time" />
	<meta name="twitter:data1" content="15 minutes" />
	<script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"WebSite","@id":"https://www.merck.com/#website","url":"https://www.merck.com/","name":"Merck.com","description":"Just another vip-msd.com site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://www.merck.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/#primaryimage","inLanguage":"en-US","url":"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20220208005551r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en","contentUrl":"https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20220208005551r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"},{"@type":"WebPage","@id":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/#webpage","url":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/","name":"Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States - Merck.com","isPartOf":{"@id":"https://www.merck.com/#website"},"primaryImageOfPage":{"@id":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/#primaryimage"},"datePublished":"2022-02-08T11:45:00+00:00","dateModified":"2022-10-04T04:08:03+00:00","breadcrumb":{"@id":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/"]}]},{"@type":"BreadcrumbList","@id":"https://www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https://www.merck.com/news-archive/"},{"@type":"ListItem","position":2,"name":"Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States"}]}]}</script>
	<!-- / Yoast SEO plugin. -->


<link rel='dns-prefetch' href='http://s.w.org/' />
<link rel='dns-prefetch' href='http://v0.wordpress.com/' />
<link rel='stylesheet' id='single-news-styles-css'  href='../../wp-content/themes/mhh-merck-mco-theme/css/single-news_item.min873c.css?ver=20200302' media='all' />
<link rel='stylesheet' id='wp-block-library-css'  href='../../wp-includes/css/dist/block-library/style.min9bd2.css?ver=5.9.4' media='all' />
<style id='wp-block-library-inline-css'>
.has-text-align-justify{text-align:justify;}
</style>
<link rel='stylesheet' id='mediaelement-css'  href='../../wp-includes/js/mediaelement/mediaelementplayer-legacy.min08e1.css?ver=4.2.16' media='all' />
<link rel='stylesheet' id='wp-mediaelement-css'  href='../../wp-includes/js/mediaelement/wp-mediaelement.min9bd2.css?ver=5.9.4' media='all' />
<link rel='stylesheet' id='elasticpress-related-posts-block-css'  href='../../wp-content/mu-plugins/search/elasticpress/dist/css/related-posts-block-styles.min3ab2.css?ver=3.6.5' media='all' />
<style id='global-styles-inline-css'>
body{--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--duotone--dark-grayscale: url('#wp-duotone-dark-grayscale');--wp--preset--duotone--grayscale: url('#wp-duotone-grayscale');--wp--preset--duotone--purple-yellow: url('#wp-duotone-purple-yellow');--wp--preset--duotone--blue-red: url('#wp-duotone-blue-red');--wp--preset--duotone--midnight: url('#wp-duotone-midnight');--wp--preset--duotone--magenta-yellow: url('#wp-duotone-magenta-yellow');--wp--preset--duotone--purple-green: url('#wp-duotone-purple-green');--wp--preset--duotone--blue-orange: url('#wp-duotone-blue-orange');--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}
</style>
<link rel='stylesheet' id='all-css-12' href='../../wp-content/plugins/seriously-simple-podcasting/assets/css/recent-episodes4fe0.css?m=1664556542g' type='text/css' media='all' />
<link rel='stylesheet' id='qm-objectcache-style-css'  href='../../wp-content/mu-plugins/qm-plugins/qm-object-cache/css/styleb3e8.css?ver=0.1' media='all' />
<link rel='stylesheet' id='Mco-styles-css'  href='../../wp-content/themes/mhh-merck-mco-theme/css/style.min367c.css?ver=20190301' media='all' />
<link rel="https://api.w.org/" href="../../wp-json/index.html" /><link rel="alternate" type="application/json" href="../../wp-json/wp/v2/news_item/3537641.json" /><link rel='shortlink' href='../../index87ba.html?p=3537641' />
<link rel="alternate" type="application/json+oembed" href="../../wp-json/oembed/1.0/embededc3.json?url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fmerck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states%2F" />
<link rel="alternate" type="text/xml+oembed" href="../../wp-json/oembed/1.0/embedb799?url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fmerck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states%2F&amp;format=xml" />

<link rel="alternate" type="application/rss+xml" title="Podcast RSS feed" href="../../feed/podcast" />

<script type="text/javascript">
var dataLayer = dataLayer || [];
dataLayer.push({"user":{"role":"visitor","isLoggedIn":false}});
dataLayer.push({"site":[]});
dataLayer.push({"page":{"page_wpid":"3537641","page_language":"en_us","page_lineofbusiness":"human health","page_accessibility":"publish","page_title":"merck and ridgeback announce that 3.1 million courses of molnupiravir, an investigational oral antiviral covid-19 medicine, have been supplied to the u.s. government for use in the united states"}});
</script>
<script type="text/javascript">
(
        function( w, d, s, l, i ) {
            w[l] = w[l] || [];
            w[l].push( {'gtm.start': new Date().getTime(), event: 'gtm.js'} );
					var f = d.getElementsByTagName( s )[0],
						j = d.createElement( s ), dl = l !== 'dataLayer' ? '&l=' + l : '';
					j.async = true;
					j.src = '../../../www.googletagmanager.com/gtm5445.html?id=' + i + dl;
					f.parentNode.insertBefore( j, f );
				}
        )( window, document, 'script', 'dataLayer', 'GTM-M74WZDM' );
</script>
<meta name="page_wpid" content="3537641" /><meta name="page_language" content="en_US" /><meta name="page_lineofbusiness" content="Human Health" /><meta name="page_accessibility" content="publish" /><meta name="page_title" content="merck and ridgeback announce that 3.1 million courses of molnupiravir, an investigational oral antiviral covid-19 medicine, have been supplied to the u.s. government for use in the united states" />        <link rel="apple-touch-icon" sizes="180x180" href="../../wp-content/themes/mhh-merck-mco-theme/images/apple-touch-icon.png">
    <link rel="icon" type="image/png" sizes="32x32" href="../../wp-content/themes/mhh-merck-mco-theme/images/favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../../wp-content/themes/mhh-merck-mco-theme/images/favicon-16x16.png">

    <link rel="manifest" href="../../wp-content/themes/mhh-merck-mco-theme/images/site.webmanifest">
    <link rel="mask-icon" href="../../wp-content/themes/mhh-merck-mco-theme/images/safari-pinned-tab.svg" color="#ffffff">
    <link rel="shortcut icon" href="../../wp-content/themes/mhh-merck-mco-theme/images/favicon.ico">
    <meta name="msapplication-TileColor" content="#ffffff">
    <meta name="msapplication-config" content="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/browserconfig.xml">
    <meta name="theme-color" content="#ffffff">
    
<style>
    :root {
        --colorTextPrimary: #000000;
        --colorPrimary: #00857C;
        --colorPrimaryLight: #6ECEB2;
        --colorPrimaryDark: #005C55;
        --colorPrimaryDarkBlue: #0C2340;
        --colorSecondaryLime: #BFED33;
        --colorSecondaryLemon: #FFF063;
        --colorSecondaryPastelBlue: #69B8F7;
        --colorSecondaryVistaBlue: #688CE8;
        --colorSecondaryRichBlue: #5450E4;
        --colorBlack: #000000;
        --colorWhite: #FFFFFF;
        --colorOffWhite: #F7F7F7;
        --colorGray: #757575;
        --colorWarning: #FE0000;
        --colorSuccess: #029A01;
        --colorInfo: #1058A4;
        --colorGrayHRTwenty: #75757533;
        --colorGrayHRTen: #7575751a;
    }
</style> </head>

<body class="news_item-template-default single single-news_item postid-3537641 no-sidebar">
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-M74WZDM&amp;user%5Brole%5D=visitor&amp;user%5BisLoggedIn%5D=0&amp;page%5Bpage_wpid%5D=3537641&amp;page%5Bpage_language%5D=en_us&amp;page%5Bpage_lineofbusiness%5D=human%20health&amp;page%5Bpage_accessibility%5D=publish&amp;page%5Bpage_title%5D=merck%20and%20ridgeback%20announce%20that%203.1%20million%20courses%20of%20molnupiravir,%20an%20investigational%20oral%20antiviral%20covid-19%20medicine,%20have%20been%20supplied%20to%20the%20u.s.%20government%20for%20use%20in%20the%20united%20states" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-dark-grayscale"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0 0.49803921568627" /><feFuncG type="table" tableValues="0 0.49803921568627" /><feFuncB type="table" tableValues="0 0.49803921568627" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-grayscale"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0 1" /><feFuncG type="table" tableValues="0 1" /><feFuncB type="table" tableValues="0 1" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-purple-yellow"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0.54901960784314 0.98823529411765" /><feFuncG type="table" tableValues="0 1" /><feFuncB type="table" tableValues="0.71764705882353 0.25490196078431" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-blue-red"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0 1" /><feFuncG type="table" tableValues="0 0.27843137254902" /><feFuncB type="table" tableValues="0.5921568627451 0.27843137254902" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-midnight"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0 0" /><feFuncG type="table" tableValues="0 0.64705882352941" /><feFuncB type="table" tableValues="0 1" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-magenta-yellow"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0.78039215686275 1" /><feFuncG type="table" tableValues="0 0.94901960784314" /><feFuncB type="table" tableValues="0.35294117647059 0.47058823529412" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-purple-green"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0.65098039215686 0.40392156862745" /><feFuncG type="table" tableValues="0 1" /><feFuncB type="table" tableValues="0.44705882352941 0.4" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 0 0" width="0" height="0" focusable="false" role="none" style="visibility: hidden; position: absolute; left: -9999px; overflow: hidden;" ><defs><filter id="wp-duotone-blue-orange"><feColorMatrix color-interpolation-filters="sRGB" type="matrix" values=" .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 .299 .587 .114 0 0 " /><feComponentTransfer color-interpolation-filters="sRGB" ><feFuncR type="table" tableValues="0.098039215686275 1" /><feFuncG type="table" tableValues="0 0.66274509803922" /><feFuncB type="table" tableValues="0.84705882352941 0.41960784313725" /><feFuncA type="table" tableValues="1 1" /></feComponentTransfer><feComposite in2="SourceGraphic" operator="in" /></filter></defs></svg><div id="page" class="site">
    <a class="skip-link screen-reader-text" href="#content">Skip to content</a>

    

    <header id="masthead" class="site-header">
                <nav id="site-navigation" class="main-navigation">
            <div class="wrapper header-wrapper">
                <div class="site-branding">
            <p class="site-title">
                <a href="../../index.html" rel="home" title="Merck.com">
            <img class="site-logo" src="../../wp-content/themes/mhh-merck-mco-theme/images/logo.jpeg" alt="Site logo" />
            </a>
            </p>
    </div><!-- .site-branding -->                <div id="mastheadMenu">
    <button id="siteSearchToggle" class="btn" aria-controls="primary-search" aria-expanded="false">
        <span class="menu-toggle-text-open">
            <img src="../../wp-content/themes/mhh-merck-mco-theme/images/search-white.svg" alt="menu icon" />
            <span>Search everything</span>
        </span>
        <span class="menu-toggle-text-close">
            <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/close.svg" alt="close icon" />Close        </span>
    </button>
    <button id="siteNavigationToggle" class="btn menu-toggle" aria-controls="primary-menu" aria-expanded="false">
        <span class="menu-toggle-text-open">
            <img src="../../wp-content/themes/mhh-merck-mco-theme/images/burger-white.svg" alt="menu icon" />Menu        </span>
        <span class="menu-toggle-text-close">
            <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/close.svg" alt="close icon" />Close        </span>
    </button>
</div>            </div><!-- .header-wrapper -->
        </nav><!-- #site-navigation -->
        <nav id="site-menu" class="main-menu">
	<div class="wrapper">
		<a class="menucrumb" href="#">Main menu</a>
		<div class="menu-main-menu-container"><ul id="menuMain" class="menu-main level-0 menu-open"><li id="menu-item-666469" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666469"><a href="../../company-overview/index.html">Company</a>
<ul class="level-1">
	<li id="menu-item-666471" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666471"><a href="../../company-overview/index.html">Company overview</a></li>
	<li id="menu-item-667007" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-667007"><a href="../../stories/index.html">Stories</a></li>
	<li id="menu-item-2773656" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2773656"><a href="../../company-overview/history/index.html">History</a></li>
	<li id="menu-item-666473" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666473"><a href="../../company-overview/esg/index.html">Environmental, Social &#038; Governance (ESG)</a>
	<ul class="level-2">
		<li id="menu-item-2388650" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2388650"><a href="../../company-overview/esg/index.html">ESG overview</a></li>
		<li id="menu-item-2388653" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2388653"><a href="../../company-overview/esg/philanthropy/index.html">Philanthropy</a></li>
		<li id="menu-item-2796573" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2796573"><a href="../../company-overview/esg/merck-medical-outreach-program/index.html">Merck Medical Outreach Program</a></li>
		<li id="menu-item-2798027" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2798027"><a href="../../company-overview/esg/impact-investing/index.html">Impact investing</a></li>
		<li id="menu-item-2804132" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2804132"><a href="../../company-overview/esg/transparency-disclosures/index.html">Transparency disclosures</a></li>
		<li id="menu-item-2808199" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2808199"><a href="../../company-overview/esg/esg-resources/index.html">ESG resources</a></li>
	</ul>
</li>
	<li id="menu-item-666474" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666474"><a href="../../company-overview/leadership/index.html">Leadership</a>
	<ul class="level-2">
		<li id="menu-item-666483" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666483"><a href="../../company-overview/leadership/index.html">Leadership overview</a></li>
		<li id="menu-item-666484" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666484"><a href="../../company-overview/leadership/board-of-directors/index.html">Board of directors</a></li>
		<li id="menu-item-666485" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666485"><a href="../../company-overview/leadership/executive-team/index.html">Executive team</a></li>
	</ul>
</li>
	<li id="menu-item-666475" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666475"><a href="../../company-overview/culture-and-values/index.html">Culture &amp; values</a>
	<ul class="level-2">
		<li id="menu-item-666488" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666488"><a href="../../company-overview/culture-and-values/index.html">Culture &#038; values overview</a></li>
		<li id="menu-item-666489" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666489"><a href="../../company-overview/culture-and-values/code-of-conduct/index.html">Code of conduct &amp; compliance</a></li>
	</ul>
</li>
	<li id="menu-item-666476" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666476"><a href="../../company-overview/diversity-and-inclusion/index.html">Diversity &amp; inclusion</a></li>
	<li id="menu-item-666477" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666477"><a href="../../company-overview/policies-and-positions/index.html">Policies &amp; positions</a></li>
	<li id="menu-item-666478" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666478"><a href="../../company-overview/business-development-licensing/index.html">Business development &amp; licensing</a></li>
	<li id="menu-item-666479" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666479"><a href="../../company-overview/suppliers/index.html">Suppliers</a>
	<ul class="level-2">
		<li id="menu-item-667793" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-667793"><a href="../../company-overview/suppliers/index.html">Suppliers overview</a></li>
		<li id="menu-item-667792" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-667792"><a target="_blank" rel="noopener" href="https://msd.quantumsds.com/">Supplier registration</a></li>
		<li id="menu-item-3601080" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-3601080"><a href="https://suppliers.msd.com/">Supplier help for Ariba</a></li>
	</ul>
</li>
</ul>
</li>
<li id="menu-item-14540" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-14540"><a href="../../research/index.html">Research</a>
<ul class="level-1">
	<li id="menu-item-666505" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666505"><a href="../../research/index.html">Research overview</a></li>
	<li id="menu-item-2388262" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-2388262"><a href="../../research/covid-19/index.html">Our COVID-19 efforts</a></li>
	<li id="menu-item-666527" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-666527"><a target="_blank" rel="noopener" href="#">Areas of focus</a>
	<ul class="level-2">
		<li id="menu-item-666509" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666509"><a href="../../research/oncology/index.html">Oncology</a></li>
		<li id="menu-item-666507" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666507"><a href="../../research/vaccines/index.html">Vaccines</a></li>
		<li id="menu-item-666508" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666508"><a href="../../research/infectious-diseases/index.html">Infectious diseases</a></li>
		<li id="menu-item-666510" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666510"><a href="../../research/cardio-metabolic-disorders/index.html">Cardio-metabolic disorders</a></li>
	</ul>
</li>
	<li id="menu-item-666511" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666511"><a href="../../research/product-pipeline/index.html">Pipeline</a></li>
	<li id="menu-item-666512" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666512"><a href="../../research/discovery-development/index.html">Discovery &amp; development</a></li>
	<li id="menu-item-3600289" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-3600289"><a href="../../research/rd-locations/index.html">R&#038;D locations</a></li>
	<li id="menu-item-666513" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-666513"><a href="../../research/clinical-trials/index.html">Clinical trials</a>
	<ul class="level-2">
		<li id="menu-item-666673" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666673"><a href="../../research/clinical-trials/index.html">Clinical trials overview</a></li>
		<li id="menu-item-666672" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-666672"><a target="_blank" rel="noopener" href="https://www.merckclinicaltrials.com/">Find a trial</a></li>
		<li id="menu-item-2805336" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2805336"><a href="../../research/diversity-in-clinical-trials/index.html">Diversity in clinical trials</a></li>
	</ul>
</li>
</ul>
</li>
<li id="menu-item-3600254" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-3600254"><a href="../../products/index.html">Products</a>
<ul class="level-1">
	<li id="menu-item-666506" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666506"><a href="../../products/index.html">Products list</a></li>
	<li id="menu-item-666515" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666515"><a href="../../products/patent/index.html">Product patents</a></li>
	<li id="menu-item-14541" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-14541"><a href="../../products/distributors/index.html">Merck authorized distributors</a></li>
</ul>
</li>
<li id="menu-item-628574" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-628574"><a href="../../patients/index.html">Patients</a>
<ul class="level-1">
	<li id="menu-item-2784133" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2784133"><a href="../../patients/index.html">Patients overview</a></li>
	<li id="menu-item-2181846" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2181846"><a href="../../patients/patient-financial-assistance/index.html">Patient support programs</a></li>
	<li id="menu-item-628576" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-628576"><a href="../../patients/patient-resources/index.html">Patient resources</a></li>
	<li id="menu-item-628575" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-628575"><a href="../../patients/patient-and-treatment-education/index.html">Patient &amp; treatment education</a></li>
</ul>
</li>
<li id="menu-item-666493" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-666493"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en">Careers</a>
<ul class="level-1">
	<li id="menu-item-696146" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696146"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/home">Careers</a></li>
	<li id="menu-item-696145" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696145"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/search-results">Search jobs</a></li>
	<li id="menu-item-696144" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-696144"><a href="#">Our divisions</a>
	<ul class="level-2">
		<li id="menu-item-696175" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696175"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/research-laboratories">Research &#038; development</a></li>
		<li id="menu-item-696174" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696174"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/manufacturing">Manufacturing &#038; supply</a></li>
		<li id="menu-item-696172" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696172"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/human-health">Human Health</a></li>
		<li id="menu-item-696171" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696171"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/animal-health">Animal Health</a></li>
		<li id="menu-item-696164" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696164"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/global-support-functions">Global support functions</a></li>
	</ul>
</li>
	<li id="menu-item-696141" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696141"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/veteran-opportunities">Veterans</a></li>
	<li id="menu-item-696140" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696140"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/student-opportunities">Student opportunities</a></li>
	<li id="menu-item-696139" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696139"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/compensation-and-benefits">Compensation &#038; benefits</a></li>
	<li id="menu-item-696138" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696138"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/hiring-process">How we hire</a></li>
	<li id="menu-item-696137" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696137"><a target="_blank" rel="noopener" href="https://jobs.msd.com/gb/en/home">MSD Careers</a></li>
	<li id="menu-item-696136" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696136"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/events">Events</a></li>
	<li id="menu-item-696134" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-696134"><a target="_blank" rel="noopener" href="https://jobs.merck.com/us/en/jointalentcommunity?applyType=JTC">Talent community</a></li>
</ul>
</li>
<li id="menu-item-137022" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-137022"><a href="../../investor-relations/index.html">Investors</a>
<ul class="level-1">
	<li id="menu-item-223087" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-223087"><a href="../../investor-relations/index.html">Investors overview</a></li>
	<li id="menu-item-220674" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-220674"><a href="../../investor-relations/events-and-presentations/index.html">Events &amp; presentations</a></li>
	<li id="menu-item-220673" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-220673"><a href="../../investor-relations/financial-information/index.html">Financial information</a>
	<ul class="level-2">
		<li id="menu-item-666494" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666494"><a href="../../investor-relations/financial-information/index.html">Financial information overview</a></li>
		<li id="menu-item-666495" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666495"><a href="../../investor-relations/financial-information/sec-filings/index.html">SEC filings</a></li>
	</ul>
</li>
	<li id="menu-item-220672" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-220672"><a href="../../investor-relations/stock-info/index.html">Stock information</a></li>
	<li id="menu-item-220671" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-220671"><a href="../../investor-relations/investor-resources/index.html">Investor resources</a>
	<ul class="level-2">
		<li id="menu-item-666496" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666496"><a href="../../investor-relations/investor-resources/index.html">Investor resources overview</a></li>
		<li id="menu-item-2793045" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2793045"><a href="../../investor-relations/organon-resources/index.html">Organon resources</a></li>
		<li id="menu-item-666497" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-666497"><a href="../../investor-relations/investor-resources/information-request/index.html">Request for information</a></li>
	</ul>
</li>
</ul>
</li>
<li id="menu-item-650872" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-650872"><a href="../../media/index.html">Media</a>
<ul class="level-1">
	<li id="menu-item-650874" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-650874"><a href="../../media/index.html">Media overview</a></li>
	<li id="menu-item-650878" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-650878"><a href="../../media/news/index.html">News releases</a></li>
	<li id="menu-item-650884" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-650884"><a href="../../media/company-statements/index.html">Company statements</a></li>
	<li id="menu-item-3544562" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-3544562"><a href="../../media/media-library/index.html">Media library &amp; contacts</a>
	<ul class="level-2">
		<li id="menu-item-3544537" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-3544537"><a href="../../media/media-library/index.html">Media contact &#038; library overview</a></li>
		<li id="menu-item-650879" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-650879"><a href="../../media/media-library/company-fact-sheet/index.html">Company fact sheet</a></li>
	</ul>
</li>
</ul>
</li>
</ul></div>		<div class="side-section">
															<div class="image">
						<picture>
							<source media="(max-width: 1279px)"
								data-srcset="../../wp-content/uploads/sites/5/2021/11/covid-19-response-heroceb3.jpg?resize=370,418">
							<source media="(min-width: 1280px)"
								data-srcset="../../wp-content/uploads/sites/5/2021/11/covid-19-response-herof9f6.jpg?resize=486,432">
							<img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/uploads/sites/5/2021/11/covid-19-response-hero.jpg?resize=486,432" alt="two scientists wearing masks">
						</picture>
					</div>
													<div class="tagline"></div>
													<h4>Our COVID-19 efforts</h4>
													<a class="btn" href="../../research/covid-19/index.html" title="Learn more" target="">Learn more</a>
									</div>
		<div class="bottom-section">
			<a class="btn" href="../../contact-us/index.html">Contact us</a>
			<p>
				<a href="https://www.msd.com/contact-us/worldwide-locations/" target="_blank" rel="noopener">Worldwide</a>
				<small>Countries outside of the United States and Canada.</small>
			</p>
		</div>
	</div>
</nav><!-- #site-menu -->

        <form id="site-search" role="search" method="get" class="search-form" action="https://www.merck.com/" autocomplete="off">
    <h1>What can we help you find?</h1>
    <div id="site-search-box" class="input-box autocomplete">
        <span class="screen-reader-text">Search for:</span>
        <input type="text" class="search-field autocomplete-input" placeholder="Search here …" value="" name="s" aria-label="Search site">
        <button type="submit" class="submit search-submit"></button>
    </div>
    <div id="search_suggestion_result"></div> 
    </form>


<script>
    theme_directory = "../../wp-content/themes/mhh-merck-mco-theme/index.html";  
</script>
    </header><!-- #masthead -->
    <div id="content" class="site-content">


	<div id="primary" class="content-area">
                    <div class="breadcrumbs wrapper text-descriptive">
                <span>
                    <span>
                        <a href="../../media/index.html">
                            Media
                        </a> &gt; 
                        <span>
                            <a href="../../media/news/index.html">
                                News releases
                            </a> &gt; 
                            <span class="breadcrumb_last" aria-current="page">
                                News release
                            </span>
                        </span>
                    </span>
                </span>
            </div>
        		<main id="main" class="site-main single-news_item">
            <article id="post-3537641" class="post-3537641 news_item type-news_item status-publish hentry tag-corporate-news tag-press-release tag-research-and-development-news">

                <div class="entry-content">
                    <div class="news-itm-header-container wrapper">
                        <div>
                            <h2 class="entry-title">
                                Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States                            </h2>
                        </div>
                    </div>

                    <div class="wrapper">
                        <div class="entry-header-links-div">
                                                        <a id="btnSave2PDF" href="https://s2.q4cdn.com/584635680/files/doc_news/Merck-and-Ridgeback-Announce-That-3.1-Million-Courses-of-Molnupiravir-an-Investigational-Oral-Antiviral-COVID-19-Medicine-Have-Been-S-4P3CA.pdf" target="_blank"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 16 16">
    <path fill="#00857C" d="M2.556 3.894v9.326h10.888V3.894H15v9.326c0 .863-.7 1.555-1.556 1.555H2.556A1.555 1.555 0 0 1 1 13.22V3.894h1.556zM8.924.775v8.59L10.9 7.391l1.1 1.1-3.85 3.85-3.85-3.85 1.1-1.1 1.974 1.974V.775h1.551z" />
</svg>
 Save</a>
                                                        </div>
                        
                        <div class="news-item-text-container">
                            <p class="date-text">
                                February 8, 2022 6:45 am ET                            </p>
                            <p class="bwalignc">
  <b>Merck Has Completed Manufacturing of 10 Million Courses of Therapy and Remains on Track to Produce at Least 20 Million Courses in 2022 to Provide Widespread Access to Molnupiravir Globally</b>
</p><p>    KENILWORTH, N.J. &amp; MIAMI--(BUSINESS WIRE)--
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately 3.1 million courses of molnupiravir, an investigational oral antiviral COVID-19 medicine, have been provided to the U.S. government for allocation across the country. The U.S. Department of Health and Human Services (HHS) has created a public <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcovid-19-therapeutics-locator-dhhs.hub.arcgis.com%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=website&amp;index=1&amp;md5=9fe3f2e66362d496fd90e3c6a054d496">website</a> to help providers identify locations that have received shipments of government-procured COVID-19 therapeutics available under Emergency Use Authorization. In 2021, Merck <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fmerck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=entered&amp;index=2&amp;md5=aaf9c2d8fe2d09e5c786620248985da2">entered</a> a procurement agreement with the U.S. government under which the company agreed to supply approximately 3.1 million courses of molnupiravir to the U.S. government upon Emergency Use Authorization or approval from the U.S. Food and Drug Administration.
</p><p id="news-body-cta">This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20220208005551/en/" rel="nofollow">https://www.businesswire.com/news/home/20220208005551/en/</a></p><p>
“As we start 2022, more than 2,000 COVID-19 deaths are being reported in the U.S. daily, which underscores the need for medicines including molnupiravir that can be taken at home. In line with our commitment to accelerating access to molnupiravir in the U.S., we have now supplied more than 3 million courses to the U.S. government within approximately 7 weeks of receiving Emergency Use Authorization from the U.S. Food and Drug Administration,” said Robert M. Davis, chief executive officer and president, Merck. “I am grateful to our colleagues who have worked tirelessly over the past year to accomplish this goal and to the health care providers who remain on the front lines of caring for patients with COVID-19.”
</p><p>
“We believe that molnupiravir will be a critical addition in helping curb the impact of COVID-19 on patients and health care systems in the U.S., particularly with the medicine’s antiviral activity against many variants of concern. We will continue to work with urgency to bring this important medicine to appropriate patients as quickly as possible,” said Wendy Holman, chief executive officer, Ridgeback Biotherapeutics.
</p><p>
In addition to the U.S. agreement, Merck has entered into advance purchase and supply agreements for molnupiravir in more than 30 markets worldwide, including Australia, Canada, Korea, Japan, Thailand, Ukraine and United Kingdom, pending regulatory authorizations, and is currently in discussions with additional governments. To date, Merck has shipped molnupiravir to more than 25 countries; in countries where it is approved or authorized, patients have begun to receive the medicine.
</p><p>
  <b>About Merck’s Global Efforts to Accelerate Access to Molnupiravir Following Regulatory Authorizations or Approvals</b>
</p><p>
Global access has been a priority for Merck and Ridgeback since the inception of their molnupiravir collaboration. The companies are committed to providing timely access to molnupiravir globally through our comprehensive supply and access approach, which includes investing at risk to produce millions of courses of therapy; tiered pricing based on the ability of governments to finance health care; entering into supply agreements with governments; allocating up to 3 million courses of therapy for distribution through UNICEF and the ACT Accelerator Therapeutics Partnership; and granting voluntary licenses to generic manufacturers and to the Medicines Patent Pool to make generic molnupiravir available in more than 100 low- and middle-income countries following local regulatory authorizations or approvals.
</p><p>
  <b>Supply:</b> In anticipation of the results from MOVe-OUT and the potential for regulatory authorization or approval, Merck produced molnupiravir at risk, manufacturing 10 million courses of treatment by the end of 2021, with at least 20 million courses expected to be produced in 2022. To date, Merck has shipped molnupiravir to over 25 markets, including approximately 3.1 million patient courses supplied to the U.S. government; in countries where it is approved or authorized, patients have begun to receive the medicine. To supplement the supply from licensed generic manufacturers, Merck has entered an agreement with UNICEF to allocate up to 3 million courses of therapy to low- and middle-income countries through the first half of 2022.
</p><p>
  <b>Supply agreements:</b> Merck <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fmerck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=entered&amp;index=3&amp;md5=be5cd44aa93aa01dfbc645542a79ea68">entered</a> into a procurement agreement with the U.S. government under which the company has supplied approximately 3.1 million courses of molnupiravir to the U.S. government, upon Emergency Use Authorization or approval from the U.S. Food and Drug Administration. The procurement of molnupiravir was supported in whole or in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, in collaboration with the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) under contract number W911QY21C0031.
</p><p>
The U.S. Department of Health and Human Services (HHS) has created a public <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fcovid-19-therapeutics-locator-dhhs.hub.arcgis.com%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=website&amp;index=4&amp;md5=443ae90db1b8c772fc443f65bd41b1ea">website</a> to help providers locate dispensing sites that have received shipments of government-procured COVID-19 therapeutics available under Emergency Use Authorization. Merck has also entered into advance purchase and supply agreements for molnupiravir with governments for over 30 markets worldwide, including Australia, Canada, Korea, Japan, Thailand, Ukraine and United Kingdom, pending regulatory authorizations, and is currently in discussions with additional governments. Merck is implementing a tiered pricing approach based on World Bank country income criteria to reflect countries’ relative ability to finance their health response to the pandemic.
</p><p>
  <b>Voluntary licenses:</b> As part of its commitment to widespread global access, Merck previously <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fthe-medicines-patent-pool-mpp-and-merck-enter-into-license-agreement-for-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-to-increase-broad-access-in-low-and-middle-income-countri%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=announced&amp;index=5&amp;md5=b60d9bae98ce801a52cd52ad4268fe69">announced</a> that it has entered into a licensing agreement with the Medicines Patent Pool to increase broad access for molnupiravir in low- and middle-income countries. Additionally, Merck previously <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Famid-humanitarian-crisis-in-india-merck-announces-voluntary-licensing-agreements-with-five-indian-generics-manufacturers-to-accelerate-and-expand-global-access-to-molnupiravir-an-investigational-ora%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=announced&amp;index=6&amp;md5=c583db9bd1f26be8eba60aa6ca0c0ef6">announced</a> that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with established generic manufacturers to accelerate availability of molnupiravir in more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies.
</p><p>
Merck continues to discuss additional measures and collaborations to accelerate broad, global access to molnupiravir.
</p><p>
  <b>Authorized Use of Molnupiravir in the U.S.</b>
</p><p>
The U.S. Food and Drug Administration (FDA) has issued an EUA for the emergency use of the unapproved molnupiravir, a nucleoside analogue that inhibits SARS-CoV-2 replication by viral mutagenesis, for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by FDA are not accessible or clinically appropriate. Molnupiravir is not FDA-approved for any use including for use for the treatment of COVID-19. Prior to initiating treatment with molnupiravir, carefully consider the known and potential risks and benefits.
</p><p>
Molnupiravir is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of molnupiravir under section 564(b)(1) of the Federal, Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
</p><p>
Molnupiravir is not authorized for use in patients less than 18 years of age or who are hospitalized due to COVID-19. Benefit of treatment with molnupiravir has not been observed in subjects when treatment was initiated after hospitalization due to COVID-19. Molnupiravir is not authorized for use for longer than five consecutive days. Molnupiravir is not authorized for pre-exposure or post-exposure prophylaxis for prevention of COVID-19. Molnupiravir may only be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs in the therapeutic class to which molnupiravir belongs (i.e., anti-infectives).
</p><p>
  <b>Selected Safety Information for Molnupiravir</b>
</p><p>
  <b>Contraindications</b>
</p><p>
No contraindications have been identified based on the limited available data on the emergency use of molnupiravir authorized under this EUA.
</p><p>
  <b>Warnings and Precautions</b>
</p><p>
There are limited clinical data available for molnupiravir. Serious and unexpected adverse events may occur that have not been previously reported with molnupiravir use.
</p><p>
Molnupiravir is not recommended for use during pregnancy. Based on findings from animal reproduction studies, molnupiravir may cause fetal harm when administered to pregnant individuals. There are no available human data on the use of molnupiravir in pregnant individuals to evaluate the risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.
</p><p>
Molnupiravir is authorized to be prescribed to a pregnant individual only after the healthcare provider has determined that the benefits would outweigh the risks for that individual patient. If the decision is made to use molnupiravir during pregnancy, the prescribing healthcare provider must document that the known and potential benefits and the potential risks of using molnupiravir during pregnancy were communicated to the pregnant individual.
</p><p>
There is a pregnancy surveillance program that monitors pregnancy outcomes in individuals exposed to molnupiravir during pregnancy. The prescribing healthcare provider must document that a pregnant individual was made aware of Merck’s pregnancy surveillance program at 1-877-888-4231 or pregnancyreporting.msd.com. If the pregnant individual agrees to participate in the pregnancy surveillance program and allows the prescribing healthcare provider to disclose patient specific information to Merck, the prescribing healthcare provider must provide the patient’s name and contact information to Merck. Pregnant individuals exposed to molnupiravir can also report the exposure by contacting Merck at 1-877-888-4231 or pregnancyreporting.msd.com.
</p><p>
Advise individuals of childbearing potential of the potential risk to a fetus and to use an effective method of contraception correctly and consistently during treatment with molnupiravir and for 4 days after the final dose.
</p><p>
Prior to initiating treatment with molnupiravir, assess whether an individual of childbearing potential is pregnant or not, if clinically indicated.
</p><p>
Molnupiravir is not authorized for use in patients less than 18 years of age because it may affect bone and cartilage growth. The safety and efficacy of molnupiravir have not been established in pediatric patients.
</p><p>
  <b>Adverse Reactions</b>
</p><p>
The most common adverse reactions occurring in ≥1% of subjects in the molnupiravir treatment group in the Phase 3 double-blind MOVe-OUT study were diarrhea (2% versus placebo at 2%), nausea (1% versus placebo at 1%), and dizziness (1% versus placebo at 1%) all of which were Grade 1 (mild) or Grade 2 (moderate).
</p><p>
Serious adverse events occurred in 7% of subjects receiving molnupiravir and 10% receiving placebo; most serious adverse events were COVID-19 related. Adverse events leading to death occurred in 2 (&lt;1%) of the subjects receiving molnupiravir and 12 (2%) of subjects receiving placebo.
</p><p>
  <b>Drug Interactions</b>
</p><p>
No drug interactions have been identified based on the limited available data on the emergency use of molnupiravir. No clinical drug-drug interaction trials of molnupiravir with concomitant medications, including other treatments for mild to moderate COVID-19, have been conducted.
</p><p>
  <b>Pregnancy/Breastfeeding</b>
</p><p>
There are no data on the presence of molnupiravir or its metabolites in human milk. It is unknown whether molnupiravir has an effect on the breastfed infant or effects on milk production. Based on the potential for adverse reactions in the infant from molnupiravir, breastfeeding is not recommended during treatment with molnupiravir and for 4 days after the final dose. A lactating individual may consider interrupting breastfeeding and may consider pumping and discarding breast milk during treatment and for 4 days after the last dose of molnupiravir.
</p><p>
  <b>Males of Reproductive Potential</b>
</p><p>
Nonclinical studies to fully assess the potential for molnupiravir to affect offspring of treated males have not been completed. Advise sexually active individuals with partners of childbearing potential to use a reliable method of contraception correctly and consistently during treatment and for at least 3 months after last dose of molnupiravir. The risk beyond three months after the last dose of molnupiravir is unknown.
</p><p>
  <b>Required Reporting for Serious Adverse Events and Medication Errors</b>
</p><p>
The prescribing healthcare provider and/or the provider’s designee are/is responsible for mandatory reporting of all serious adverse events and medication errors potentially related to molnupiravir within 7 calendar days from the healthcare provider’s awareness of the event.
</p><p>
Submit adverse event and medication error reports, using FDA Form 3500, to FDA MedWatch using one of the following methods:
</p><ul class="bwlistdisc">
  <li>
Complete and submit the report online: <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.fda.gov%2Fmedwatch%2Freport.htm&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=www.fda.gov%2Fmedwatch%2Freport.htm&amp;index=7&amp;md5=32db502ad00d41be111cdd86d39fdd8a">www.fda.gov/medwatch/report.htm</a></li>
  <li>
Complete and submit a postage-paid FDA Form 3500 (<a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F76299%2Fdownload&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F76299%2Fdownload&amp;index=8&amp;md5=04063100e4af3f6535e889f83a0efa61">https://www.fda.gov/media/76299/download</a>) and return by:
<ul class="bwlistcircle"><li>
Mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787, or
</li><li>
Fax to 1-800-FDA-0178
</li></ul></li>
  <li>
Call 1-800-FDA-1088 to request a reporting form
</li>
</ul><p>
In addition, please provide a copy of all FDA MedWatch forms to:
</p><p class="bwmarginl1">
Merck Sharp &amp; Dohme Corp., a subsidiary of Merck &amp; Co., Inc., Kenilworth, NJ USA by:
<br>Fax: 215-616-5677
<br>E-mail: <a rel="nofollow" href="mailto:dpoc.usa@merck.com">dpoc.usa@merck.com</a></p><p>
  <b>About Molnupiravir</b>
</p><p>
Molnupiravir (MK-4482) is an investigational, orally administered nucleoside analog that inhibits the replication of SARS-CoV-2, the causative agent of COVID-19.
</p><p>
Merck and Ridgeback’s “orange COVID-19 pill” is a Swedish Orange opaque capsule with the Merck corporate logo and “82” printed in white ink, available in certain markets outside of the U.S. as LAGEVRIO<sup>®</sup>.
</p><p>
Results from the Phase 3 MOVe-OUT study demonstrated the efficacy benefit of molnupiravir treatment was generally consistent across patients infected with SARS-CoV-2 variants of concern, Delta, Gamma and Mu. Preclinical data has shown that molnupiravir has antiviral activity against the newly identified variant, Omicron (B1.1.529). Molnupiravir has yet to be evaluated against Omicron in clinical studies.
</p><p>
Molnupiravir was invented at Emory University. Drug Innovation Ventures at Emory (DRIVE), LLC, which was formed by Emory to develop early-stage drug candidates for viral diseases of global concern, advanced molnupiravir through IND submission. Emory/DRIVE received some research funding from the U.S. Department of Defense and the U.S. National Institutes of Health. Molnupiravir is being developed by Merck in collaboration with Ridgeback Biotherapeutics. Ridgeback received an upfront payment from Merck and also is eligible to receive contingent payments dependent upon the achievement of certain developmental and regulatory approval milestones. Any profits from the collaboration will be split between the partners equally. Since licensed by Ridgeback, all funds used for the development of molnupiravir have been provided by Merck and Ridgeback.
</p><p>
Molnupiravir was evaluated in MOVe-OUT, a global Phase 3, randomized, placebo-controlled, double-blind, multi-site study of non-hospitalized adult patients with symptomatic, laboratory-confirmed mild to moderate COVID-19 and at least one risk factor associated with poor disease outcomes. The Phase 3 portion of the MOVe-OUT trial was conducted globally in more than 170 sites in locations including Argentina, Brazil, Canada, Chile, Colombia, Egypt, France, Germany, Guatemala, Israel, Italy, Mexico, Philippines, Poland, Russia, South Africa, Spain, Sweden, Taiwan, Ukraine, the United Kingdom and the United States. For further information about the MOVe-OUT trial, please visit <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04575597%3Fterm%3Dmolnupiravir%26draw%3D2%26rank%3D2&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=clinicaltrials.gov&amp;index=9&amp;md5=ab1e516844f98a101c0d4ad5ea5e3299">clinicaltrials.gov</a>. Molnupiravir is also being <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fnews%2Fmerck-and-ridgeback-biotherapeutics-announce-initiation-of-pivotal-phase-3-move-ahead-study-evaluating-molnupiravir-for-post-exposure-prophylaxis-of-covid-19-infection%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=evaluated&amp;index=10&amp;md5=5bb079dc14ff0a6a19f98123f416a7ce">evaluated </a>for post-exposure prophylaxis in MOVe-AHEAD, a global, multicenter, randomized, double-blind, placebo-controlled Phase 3 study evaluating the efficacy and safety of molnupiravir in preventing the spread of COVID-19 within households. For more information, please visit <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmerckcovidresearch.com%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=http%3A%2F%2Fmerckcovidresearch.com&amp;index=11&amp;md5=21733e90afb9b8e932115ef7c0bbc762">http://merckcovidresearch.com</a>.
</p><p>
Please visit the Merck <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Fmedia%2Four-investigational-covid-19-antiviral%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=media+library&amp;index=12&amp;md5=b67e0cf8c4db9ece9d67012c2c40a3d8">media library</a> for molnupiravir images and b-roll.
</p><p>
  <b>About Ridgeback Biotherapeutics</b>
</p><p>
Headquartered in Miami, Florida, Ridgeback Biotherapeutics LP is a biotechnology company focused on emerging infectious diseases. Ridgeback markets Ebanga™&nbsp; for the treatment of Ebola and has a late-stage development pipeline which includes molnupiravir for the treatment of COVID-19. The team at Ridgeback is dedicated to developing life-saving and life-changing solutions for patients and diseases that need champions as well as providing global access to these medicines. In line with Ridgeback’s mission for equitable global access, all Ridgeback services and treatment for Ebola patients in Africa are delivered free of charge.
</p><p>
  <b>About Merck</b>
</p><p>
For over 130 years, Merck, known as MSD outside the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.merck.com&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=www.merck.com&amp;index=13&amp;md5=9efdfa0c6e52eeacbf7a9bfa0e1c867b">www.merck.com</a> and connect with us on <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FMerck&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=Twitter&amp;index=14&amp;md5=0ac04c860e13938cc2b026ac674dce6c">Twitter</a>, <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FMerckInvents%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=Facebook&amp;index=15&amp;md5=a7c4de8b94268f6e1f50d97efb74d856">Facebook</a>, <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fmerck%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=Instagram&amp;index=16&amp;md5=57bd5c18110832b7f8de68a8f0484aaf">Instagram</a>, <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.youtube.com%2FMerck&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=YouTube&amp;index=17&amp;md5=6c27bf063ea39f6033d606baab1a980f">YouTube</a> and <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fmerck&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=18&amp;md5=8c5bf7984c9248a6d42f345d98465126">LinkedIn</a>.
</p><p>
  <b>Forward-Looking Statement of Merck &amp; Co., Inc., Kenilworth, N.J., USA.</b>
</p><p>
This news release of Merck &amp; Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
</p><p>
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
</p><p>
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (<a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov%2F&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=19&amp;md5=0a6ac95d3a8ee00d2cf0216ae4032265">www.sec.gov</a>).
</p><p>
  <b>Please see the Molnupiravir FDA Letter of Authorization at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Feua%2FMerck-EUA-letter.pdf&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.merck.com%2Feua%2FMerck-EUA-letter.pdf&amp;index=20&amp;md5=0473cf820d02712b3780fd9abd9e324f">https://www.merck.com/eua/Merck-EUA-letter.pdf</a>, Fact Sheet for Healthcare Providers, including Mandatory Requirements for Administration of Molnupiravir under Emergency Use Authorization, at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Feua%2Fmolnupiravir-hcp-fact-sheet.pdf&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.merck.com%2Feua%2Fmolnupiravir-hcp-fact-sheet.pdf&amp;index=21&amp;md5=23cfe24b0e25d93597b4c7921c9dac3b">https://www.merck.com/eua/molnupiravir-hcp-fact-sheet.pdf</a> and Fact Sheet for Patients and Caregivers at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.merck.com%2Feua%2Fmolnupiravir-patient-fact-sheet-english.pdf&amp;esheet=52575535&amp;newsitemid=20220208005551&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.merck.com%2Feua%2Fmolnupiravir-patient-fact-sheet-english.pdf&amp;index=22&amp;md5=75244b7141abcac7e902f8875ba24c01">https://www.merck.com/eua/molnupiravir-patient-fact-sheet-english.pdf</a>.</b>
</p><p>
  <img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20220208005551r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en" style="width:0;height:0">
  <span class="bwct31415"></span>
</p><p id="mmgallerylink">
  <span id="mmgallerylink-phrase">View source version on <a href="http://businesswire.com/">businesswire.com</a>: </span>
  <span id="mmgallerylink-link">
    <a href="https://www.businesswire.com/news/home/20220208005551/en/" rel="nofollow">https://www.businesswire.com/news/home/20220208005551/en/</a>
  </span>
</p><p>
Media:
</p><p>
Melissa Moody
<br>(215) 407-3536
</p><p>
Courtney Ronaldo
<br>(908) 442-5695
</p><p>
Investor:
</p><p>
Peter Dannenbaum
<br>(908) 740-1037
</p><p>
Damini Chokshi
<br>(908) 740-1807
</p><p>Source: Merck &amp; Co., Inc.</p></div>                        </div>
                        
                    </div>      

                                            <div id="sidebar-news" class="sidebar">
                            
                            <h2>Multimedia</h2>                                        <p>
                                            <a href="../../../s2.q4cdn.com/584635680/files/doc_multimedia/Ridgeback.jpg" target="_blank">Ridgeback</a> <span class="text-descriptive">(44 KB)</span>
                                        </p>
                                                                            <p>
                                            <a href="../../../s2.q4cdn.com/584635680/files/doc_multimedia/Merck_Logo_Horizontal_Teal-Grey_RGB.jpg" target="_blank">Merck Logo Horizontal Teal Grey RGB</a> <span class="text-descriptive">(211 KB)</span>
                                        </p>
                                                            </div>
                                    </div><!-- .entry-content -->
                <div class="opt-in-communication-wrapper wrapper no-secondary-image" id="opt-in-communication-block-block_5e949a66cfcc9" aria-hidden="true">

                    <div class="opt-in-communication-block img-wrapper" style="position: relative;">
                        <picture class="opt-in-primary-img">
                            <source media="(max-width: 767px)" srcset="../../wp-content/themes/mhh-merck-mco-theme/images/news-release-opt-in-image-1a83.png?resize=321,196">
                            <source media="(min-width: 768px) and (max-width: 1279px)" srcset="../../wp-content/themes/mhh-merck-mco-theme/images/news-release-opt-in-image-bf9a.png?resize=656,432">
                            <source media="(min-width: 1280px)" srcset="../../wp-content/themes/mhh-merck-mco-theme/images/news-release-opt-in-image-7361.png?resize=516,596">
                            <img class="opt-in-primary-img lazyload" loading="lazy" src="../../wp-content/themes/mhh-merck-mco-theme/images/news-release-opt-in-image-7361.png?resize=516,596" alt="opt-in primary image"/>
                        </picture>
                    </div>

                    <div class="opt-in-left">
                        <div class="opt-in-left-content">
                                <h2 class="opt-in-title">Sign up for email alerts</h2>
                            <p class="opt-in-caption"></p>
                        </div>
                        <div class="opt-in-communication-block-iframe-holder">
                            <iframe id="opt-in-communication-block-block_5e949a66cfcc9-iFrame" src="https://merck2016rd.q4web.com/Email-Signup-New-Release/" style="width: 100%; overflow: hidden; height: 491px;" scrolling="no" frameborder="0"></iframe>
                            <script>
                                try {
                                    function iFrameResizerDefer(method) { if (typeof iFrameResize === "function") { method(); } else { setTimeout(function() { iFrameResizerDefer(method) }, 50); } }
                                    document.getElementById('opt-in-communication-block-block_5e949a66cfcc9-iFrame').onload = function() { iFrameResize({log:false}); };
                                } catch(ex) {
                                    console.log(ex);
                                } 
                            </script>

                        </div>
                    </div>

                </div>
                <p class="wrapper"><a href="../../investor-relations/email-alerts/index.html" class="btn secondary">Unsubscribe from email alerts</a></p>
                <footer class="entry-footer">
                                    </footer><!-- .entry-footer -->
            </article><!-- #post-3537641 -->
		
        </main><!-- #main -->
	</div><!-- #primary -->
    
    <div class="related-content-container">
        <h4>Related links</h4>
        <div class="related-content-section">
            <div class="related-content-item">
                <a href="../../media/company-statements/index.html">
                    <div class="related-content-item-image-contianer">
                        <picture>
                            <source media="(max-width: 767px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-1-.png?resize=348,324">
                            <source media="(min-width: 768px) and (max-width: 1279px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-1-.png?resize=341,524">
                            <source media="(min-width: 1280px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-1-.png?resize=666,664">
                            <img  class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-1-.png" alt="related content image #1"/>
                        </picture>
                    </div>
                    <div class="related-content-content-container">
                        <p><strong>Company Statements</strong></p>
                        <p class="realted-content-excerpt">Read our latest company statements.</p>
                    </div>
                </a>
            </div>

            <div class="related-content-item">
                <a href="../../media/media-library/index.html">
                    <div class="related-content-item-image-contianer">
                        <picture>
                            <source media="(max-width: 767px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-2.png?resize=348,324">
                            <source media="(min-width: 768px) and (max-width: 1279px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-2.png?resize=341,524">
                            <source media="(min-width: 1280px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-2.png?resize=666,664">
                            <img  class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-2.png" alt="related content image #2"/>
                        </picture>
                    </div>
                    <div class="related-content-content-container">
                        <p><strong>Media library</strong></p>
                        <p class="realted-content-excerpt">Access videos, logos, photos, and infographics.</p>
                    </div>
                </a>
            </div>

            <div class="related-content-item">
                <a href="../../company-overview/index.html">
                    <div class="related-content-item-image-contianer">
                        <picture>
                            <source media="(max-width: 767px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-3.png?resize=348,324">
                            <source media="(min-width: 768px) and (max-width: 1279px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-3.png?resize=341,524">
                            <source media="(min-width: 1280px)"
                                srcset="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-3.png?resize=666,664">
                            <img  class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/stories-rl-3.png" alt="related content image #3"/>
                        </picture>
                    </div>
                    <div class="related-content-content-container">
                        <p><strong>About Merck</strong></p>
                        <p class="realted-content-excerpt">We are committed to providing leading innovations for today and the future that save and improve lives around the world.</p>
                    </div>
                </a>
            </div>
        </div>
    </div>

</div><!-- #content -->
<footer id="footerMain" class="footer">
    <div id="footerSocial">
        <div class="wrapper">
            <h3>Connect with us on social</h3>
            <div class="social-icons">
                                    <a href="https://twitter.com/Merck" target="_blank">
                        <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/twitter-brands.svg" alt="social icon" />
                    </a>
                                    <a href="https://www.facebook.com/MerckInvents" target="_blank">
                        <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/facebook-f-brands.svg" alt="social icon" />
                    </a>
                                    <a href="https://www.linkedin.com/company/merck" target="_blank">
                        <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/linkedin-brands.svg" alt="social icon" />
                    </a>
                                    <a href="https://www.instagram.com/merck" target="_blank">
                        <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/instagram-brands.svg" alt="social icon" />
                    </a>
                                    <a href="https://www.youtube.com/user/Merck" target="_blank">
                        <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/youtube-brands.svg" alt="social icon" />
                    </a>
                            </div>
        </div>
    </div>
    <div class="wrapper">
        <div id="footerPrograms">
                            <div class="column col-one">
                    <input type="checkbox" id="columnOne" class="checkbox-toggle">
                    <label for="columnOne" class="column-header">For patients and health care professionals</label>
                    <ul>
                        <li><a href="https://www.merckhelps.com/" target="_blank" rel="noopener">MerckHelps</a><br>
                            Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients</li>
                        <li><a href="https://www.merckaccessprogram.com/" target="_blank" rel="noopener">Merck Access Program</a><br>
                            Information about insurance coverage and financial assistance options for eligible patients</li>
                        <li><a href="https://www.merckclinicaltrials.com/" target="_blank" rel="noopener">Clinical trials</a><br>
                            Learn about our clinical trials and find available studies</li>
                        <li><a href="https://www.merckmanuals.com/" target="_blank" rel="noopener">Merck Manuals</a><br>
                            Medical information source covering thousands of topics in all fields of medicine</li>
                    </ul>
                </div>
            
                            <div class="column col-two">
                    <input type="checkbox" id="columnTwo" class="checkbox-toggle">
                    <label for="columnTwo" class="column-header">Environmental, Social &amp; Governance (ESG)</label>
                    <ul>
                                                    <li>
                                <a href="../../company-overview/esg/index.html" target="_blank" rel="noopener">Environmental, Social &amp; Governance (ESG) Report</a>
                                                                    <br />
                                    Reporting on our commitment to operating responsibly to benefit society                                                            </li>
                                                    <li>
                                <a href="https://www.merckformothers.com/" target="_blank" rel="noopener">Merck for Mothers</a>
                                                                    <br />
                                    An initiative to create a world where no woman has to die giving life                                                            </li>
                                            </ul>
                </div>
            
                            <div class="column col-three">
                    <input type="checkbox" id="columnThree" class="checkbox-toggle">
                    <label for="columnThree" class="column-header">About Merck</label>
                    <ul>
                        <li><a href="https://www.merck-animal-health.com/" target="_blank" rel="noopener">Merck Animal Health</a><br>
                            The global animal health business unit of Merck</li>
                        <li><a href="https://horizonblue.sapphiremrfhub.com/tocs/current/merck-co-inc" target="_blank" rel="noopener">Health Plan - Transparency in Coverage</a><br>
                            In compliance with the Consolidated Appropriations Act, learn more about our health plan's pricing information.</li>
                    </ul>
                </div>
                    </div>
        <div id="footerCopyrightLogos">
            <div id="footerCopyright">
                		<div class="menu-footer-menu-container"><ul id="menuFooter" class="footer-links"><li id="menu-item-674051" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-674051"><a href="../../forward-looking-statement/index.html">Forward-looking statement</a></li>
<li id="menu-item-137027" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-137027"><a target="_blank" rel="noopener" href="https://www.msdprivacy.com/us/en/cookie-privacy-policy.html">Cookie policy</a></li>
<li id="menu-item-763862" class="ot-sdk-show-settings menu-item menu-item-type-custom menu-item-object-custom menu-item-763862"><a href="#">Cookie Preferences</a></li>
<li id="menu-item-137025" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-137025"><a target="_blank" rel="noopener" href="https://www.msdprivacy.com/us/en/index.html">Privacy</a></li>
<li id="menu-item-137028" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-137028"><a target="_blank" rel="noopener" href="https://www.msdprivacy.com/us/en/transparency-and-privacy.html">Transparency disclosure</a></li>
<li id="menu-item-669400" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-669400"><a href="../../terms-of-use/index.html">Terms of use</a></li>
<li id="menu-item-3374425" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-3374425"><a href="https://www.msdaccessibility.com/">Accessibility</a></li>
<li id="menu-item-669401" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-669401"><a href="../../sitemap/index.html">Sitemap</a></li>
</ul></div>                <small>
                    Copyright © 2022  <a href="https://www.myknot.club/">MyKnot</a>; Co., India and its affiliates. All rights reserved. | This site is intended only for residents of the United States and Canada.                h-merck-mco-theme/images/logo.jpeg"         </small>
            </div>
            <div id="footerLogos">
                                <a href="https://www.essentialaccessibility.com/merck/?utm_source=merckhomepage&amp;utm_medium=iconlarge&amp;utm_term=eachannelpage&amp;utm_content=header&amp;utm_campaign=merck" target="_blank" rel="noopener">
                    <img class="lazyload" loading="lazy" data-src="https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/accessibility.png" alt="Accessibility icon" />
                </a>
                <!-- Truste badges -->
                <a href="http://privacy.truste.com/privacy-seal/validation?rid=140649f5-9394-46e8-bfe5-b4ea8a8c600e" target="_blank" rel="noopener">
                    <img style="border: none" class="lazyload" loading="lazy" data-src="//privacy-policy.truste.com/privacy-seal/seal?rid=140649f5-9394-46e8-bfe5-b4ea8a8c600e" alt="View Privacy Shield Verification Status" />
                </a>
                <a href="http://privacy.truste.com/privacy-seal/validation?rid=11c1aa82-b7e7-4a2f-b02e-ba935e661720" target="_blank" rel="noopener">
                    <img style="border: none" class="lazyload" loading="lazy" data-src="//privacy-policy.truste.com/privacy-seal/seal?rid=11c1aa82-b7e7-4a2f-b02e-ba935e661720" alt="View APEC CBPR Privacy Certification Status" />
                </a>
            </div>
        </div>
    </div>
</footer><!-- #footerMain -->
</div><!-- #page -->
<div id="fowardGuidanceModel" class="popup" style="display: none;">
    <div class="popup-wrapper">
        <div class="popup-content foward-guide-modal-content">

            <h3>Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA</h3>

            <div class="forward-guidance-content">
                <p>This news release of Merck &amp; Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.<br><br>

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.<br><br>

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2021 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).<br><br>

<b>No Duty to Update</b><br>

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

</p>            </div>

            <div class="btn-container text-center">
                <a href="../../index.html" class="btn tertiary">Decline</a>
                <a href="javascript:void()" class="btn tertiary negative" title="" onclick="sessionStorage.setItem('guidance-accepted', JSON.stringify(true)); document.getElementById('fowardGuidanceModel').style.display = 'none';">Accept</a>
            </div>

        </div>
    </div>
</div>
<link rel='stylesheet' id='related-content-styles-css'  href='../../wp-content/themes/mhh-merck-mco-theme/css/related-content-section.min9bd2.css?ver=5.9.4' media='all' />
<script defer="defer" src='../../wp-content/plugins/mhh-corporateberg/opt-in-communication-block/js/iframeResizer.min9bd2.js?ver=5.9.4' id='iframe-resize-js-js'></script>
<script defer="defer" src='../../wp-content/themes/mhh-merck-mco-theme/js/plugins.min367c.js?ver=20190301' id='Mco-plugins-js'></script>
<script defer="defer" src='../../wp-content/themes/mhh-merck-mco-theme/js/scripts.min367c.js?ver=20190301' id='Mco-scripts-js'></script>
<script defer="defer" src='../../wp-content/themes/mhh-merck-mco-theme/js/search_suggestions.min116a.js?ver=1664901105' id='search_suggestion-js'></script>
<div id="externalLinkModal" class="popup" style="display: none;">
    <div class="popup-wrapper">
        <div class="popup-content foward-guide-modal-content">

            <h3 id="externalLinkModalTitle">You are leaving Merck.com</h3>

            <div class="forward-guidance-content">
                <p id="externalLinkModalMessage" style="max-width: 31.25rem;"></p>
            </div>
            
            <div class="btn-container text-center">
                <button class="btn tertiary" id="externalLinkCancelBtn" title="" onclick="document.getElementById('externalLinkModal').style.display = 'none';">Cancel</button>
                <a href="#" target="_blank" class="btn tertiary negative" id="externalLinkModalBtn">Continue</a>
            </div>
        
        </div>
    </div>
</div>

<script type="text/javascript">
    let whitelist_domains =  ".local,merck-go-vip,merck-develop.go-vip.co/merck,merck-preprod.go-vip.co/merck,vip-msd.com/merck,merck.com,q4cdn.com,cloudfront.net,wpvip-safety-data-sheets.s3.amazonaws.com,google.com/calendar,outlook.live.com/calendar,calendar.yahoo.com,merckhelps.com,merckaccessprogram.com,merckmanuals.com,merckconnect.com,merckclinicaltrials.com,merck-animal-health.com,merckformothers.com,mrknewsroom.com,facebook.com,twitter.com,linkedin.com,mailto:,javascript:,tel:";
    let whitelist_domains_array = whitelist_domains.split(',');
    whitelist_domains_array.unshift(document.location.hostname);
        // External Links
    try {
        let links = Array.from(document.links);
        for (let i = 0; i < links.length; i++) {
            let link = links[i];
            if (!shouldWhitelistDomain(link.href)) {
                link.addEventListener("click", function (e) {
                    e.preventDefault();
                    let modal_data = getLinkContent(link.href);
                    document.getElementById('externalLinkModalTitle').textContent = modal_data.title;
                    document.getElementById('externalLinkModalMessage').textContent = modal_data.message;
                    document.getElementById('externalLinkModalBtn').href = this.href;
                    document.getElementById('externalLinkModalBtn').setAttribute('onclick', 'document.getElementById(\'externalLinkModal\').style.display = "none";');
                    document.getElementById('externalLinkModal').style.display = document.getElementById('externalLinkModal').style.display === 'none' ? 'block' : 'none';
                    
                    if (modal_data.cancelBtnText){
                        document.getElementById('externalLinkCancelBtn').textContent = modal_data.cancelBtnText;

                    }
                    if (modal_data.continueBtnText){
                        document.getElementById('externalLinkModalBtn').textContent = modal_data.continueBtnText;
                    }
                });
            }
        }
    } catch(ex) {
        console.log(ex);
    }

    function getLinkContent(link) {
        try {
            let title = htmlDecode("You are leaving Merck.com");
            let message = htmlDecode("The link you have selected will direct you to a site outside of www.merck.com. We are Merck &amp; Co. Inc., Rahway, NJ, USA known as MSD outside the United States and Canada. ");
            let cancelBtnText = htmlDecode("");
            let continueBtnText = htmlDecode("");
                        data = {
                title: title,
                message: message,
                cancelBtnText: cancelBtnText,
                continueBtnText: continueBtnText
            }
            return data;
        }
        catch(ex) {
            console.log(ex);
        }
    }

    function htmlDecode(input){
        if (input === '') return '';
        var e = document.createElement('div');
        e.innerHTML = input;
        return e.childNodes[0].nodeValue;
    }

    function shouldWhitelistDomain(link){
        return whitelist_domains_array.some(domain => new RegExp(domain).test(link));
    }
</script>
<div id="ukUserModal" class="popup" style="display: none;">
    <div class="popup-wrapper">
        <div class="popup-content foward-guide-modal-content">

            <h3>Welcome to Merck.com</h3>

            <div class="forward-guidance-content">
                <p style="max-width: 31.25rem;">By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.</p>
            </div>

            <div class="btn-container text-center">
                <a target="_blank" class="btn tertiary negative" id="externalLinkModalBtn" onclick="AcceptUKMessage();">Continue</a>
            </div>

        </div>
    </div>
</div>

<script type="text/javascript">
    function AcceptUKMessage() {
        try {
            let accepted = {
                expire: new Date(new Date().getTime() + 60 * 60 * 24 * 1000)
            };
            sessionStorage.setItem('uk-messaging', JSON.stringify(accepted));
            document.getElementById('ukUserModal').style.display = 'none';
        } catch (ex) {
            console.log(ex);
        }
    }
</script>

<script>console.log("US");</script><script>
		utag_data.page_datepublished = "2022-02-08 06:45:00";
	utag_data.page_datemodified = "2022-10-04 00:08:03";
	dataLayer.push(utag_data);
</script>

	<!-- OneTrust Cookies Consent Notice start -->
	<script src="../../../cdn.cookielaw.org/scripttemplates/otSDKStub.js"  type="text/javascript" charset="UTF-8" data-domain-script="fd658a96-8c4a-4c03-973e-fd83f98fa618"></script>
	<script type="text/javascript">
		function OptanonWrapper() { }
	</script>
	<!-- OneTrust Cookies Consent Notice end -->
	<script type="text/javascript">
                        /*
* FileSaver.js
* A saveAs() FileSaver implementation.
*
* By Eli Grey, http://eligrey.com
*
* License : https://github.com/eligrey/FileSaver.js/blob/master/LICENSE.md (MIT)
* source  : http://purl.eligrey.com/github/FileSaver.js
*/

// The one and only way of getting global scope in all environments
// https://stackoverflow.com/q/3277182/1008999
var _global = typeof window === 'object' && window.window === window
  ? window : typeof self === 'object' && self.self === self
  ? self : typeof global === 'object' && global.global === global
  ? global
  : this

function bom (blob, opts) {
  if (typeof opts === 'undefined') opts = { autoBom: false }
  else if (typeof opts !== 'object') {
    console.warn('Deprecated: Expected third argument to be a object')
    opts = { autoBom: !opts }
  }

  // prepend BOM for UTF-8 XML and text/* types (including HTML)
  // note: your browser will automatically convert UTF-16 U+FEFF to EF BB BF
  if (opts.autoBom && /^\s*(?:text\/\S*|application\/xml|\S*\/\S*\+xml)\s*;.*charset\s*=\s*utf-8/i.test(blob.type)) {
    return new Blob([String.fromCharCode(0xFEFF), blob], { type: blob.type })
  }
  return blob
}

function download (url, name, opts) {
  var xhr = new XMLHttpRequest()
  xhr.open('GET.html', url)
  xhr.responseType = 'blob'
  xhr.onload = function () {
    saveAs(xhr.response, name, opts)
  }
  xhr.onerror = function () {
    console.error('could not download file')
  }
  xhr.send()
}

function corsEnabled (url) {
  var xhr = new XMLHttpRequest()
  // use sync to avoid popup blocker
  xhr.open('HEAD.html', url, false)
  try {
    xhr.send()
  } catch (e) {}
  return xhr.status >= 200 && xhr.status <= 299
}

// `a.click()` doesn't work for all browsers (#465)
function click (node) {
  try {
    node.dispatchEvent(new MouseEvent('click'))
  } catch (e) {
    var evt = document.createEvent('MouseEvents')
    evt.initMouseEvent('click', true, true, window, 0, 0, 0, 80,
                          20, false, false, false, false, 0, null)
    node.dispatchEvent(evt)
  }
}

// Detect WebView inside a native macOS app by ruling out all browsers
// We just need to check for 'Safari' because all other browsers (besides Firefox) include that too
// https://www.whatismybrowser.com/guides/the-latest-user-agent/macos
var isMacOSWebView = /Macintosh/.test(navigator.userAgent) && /AppleWebKit/.test(navigator.userAgent) && !/Safari/.test(navigator.userAgent)

var saveAs = _global.saveAs || (
  // probably in some web worker
  (typeof window !== 'object' || window !== _global)
    ? function saveAs () { /* noop */ }

  // Use download attribute first if possible (#193 Lumia mobile) unless this is a macOS WebView
  : ('download' in HTMLAnchorElement.prototype && !isMacOSWebView)
  ? function saveAs (blob, name, opts) {
    var URL = _global.URL || _global.webkitURL
    var a = document.createElement('a')
    name = name || blob.name || 'download'

    a.download = name
    a.rel = 'noopener' // tabnabbing

    // TODO: detect chrome extensions & packaged apps
    // a.target = '_blank'

    if (typeof blob === 'string') {
      // Support regular links
      a.href = blob
      if (a.origin !== location.origin) {
        corsEnabled(a.href)
          ? download(blob, name, opts)
          : click(a, a.target = '_blank')
      } else {
        click(a)
      }
    } else {
      // Support blobs
      a.href = URL.createObjectURL(blob)
      setTimeout(function () { URL.revokeObjectURL(a.href) }, 4E4) // 40s
      setTimeout(function () { click(a) }, 0)
    }
  }

  // Use msSaveOrOpenBlob as a second approach
  : 'msSaveOrOpenBlob' in navigator
  ? function saveAs (blob, name, opts) {
    name = name || blob.name || 'download'

    if (typeof blob === 'string') {
      if (corsEnabled(blob)) {
        download(blob, name, opts)
      } else {
        var a = document.createElement('a')
        a.href = blob
        a.target = '_blank'
        setTimeout(function () { click(a) })
      }
    } else {
      navigator.msSaveOrOpenBlob(bom(blob, opts), name)
    }
  }

  // Fallback to using FileReader and a popup
  : function saveAs (blob, name, opts, popup) {
    // Open a popup immediately do go around popup blocker
    // Mostly only available on user interaction and the fileReader is async so...
    popup = popup || open('', '_blank')
    if (popup) {
      popup.document.title =
      popup.document.body.innerText = 'downloading...'
    }

    if (typeof blob === 'string') return download(blob, name, opts)

    var force = blob.type === 'application/octet-stream'
    var isSafari = /constructor/i.test(_global.HTMLElement) || _global.safari
    var isChromeIOS = /CriOS\/[\d]+/.test(navigator.userAgent)

    if ((isChromeIOS || (force && isSafari) || isMacOSWebView) && typeof FileReader !== 'undefined') {
      // Safari doesn't allow downloading of blob URLs
      var reader = new FileReader()
      reader.onloadend = function () {
        var url = reader.result
        url = isChromeIOS ? url : url.replace(/^data:[^;]*;/, 'data:attachment/file;')
        if (popup) popup.location.href = url
        else location = url
        popup = null // reverse-tabnabbing #460
      }
      reader.readAsDataURL(blob)
    } else {
      var URL = _global.URL || _global.webkitURL
      var url = URL.createObjectURL(blob)
      if (popup) popup.location = url
      else location.href = url
      popup = null // reverse-tabnabbing #460
      setTimeout(function () { URL.revokeObjectURL(url) }, 4E4) // 40s
    }
  }
)

_global.saveAs = saveAs.saveAs = saveAs

if (typeof module !== 'undefined') {
  module.exports = saveAs;
}

/*! ics.js Wed Sept 14 2017 */
var ics=function(e,t){"use strict";{if(!(navigator.userAgent.indexOf("MSIE")>-1&&-1==navigator.userAgent.indexOf("MSIE 10"))){void 0===e&&(e="default"),void 0===t&&(t="Calendar");var r=-1!==navigator.appVersion.indexOf("Win")?"\r\n":"\n",n=[],i=["BEGIN:VCALENDAR","PRODID:"+t,"VERSION:2.0"].join(r),o=r+"END:VCALENDAR",a=["SU","MO","TU","WE","TH","FR","SA"];return{events:function(){return n},calendar:function(){return i+r+n.join(r)+o},addEvent:function(t,i,o,l,u,s){if(void 0===t||void 0===i||void 0===o||void 0===l||void 0===u)return!1;if(s&&!s.rrule){if("YEARLY"!==s.freq&&"MONTHLY"!==s.freq&&"WEEKLY"!==s.freq&&"DAILY"!==s.freq)throw"Recurrence rrule frequency must be provided and be one of the following: 'YEARLY', 'MONTHLY', 'WEEKLY', or 'DAILY'";if(s.until&&isNaN(Date.parse(s.until)))throw"Recurrence rrule 'until' must be a valid date string";if(s.interval&&isNaN(parseInt(s.interval)))throw"Recurrence rrule 'interval' must be an integer";if(s.count&&isNaN(parseInt(s.count)))throw"Recurrence rrule 'count' must be an integer";if(void 0!==s.byday){if("[object Array]"!==Object.prototype.toString.call(s.byday))throw"Recurrence rrule 'byday' must be an array";if(s.byday.length>7)throw"Recurrence rrule 'byday' array must not be longer than the 7 days in a week";s.byday=s.byday.filter(function(e,t){return s.byday.indexOf(e)==t});for(var c in s.byday)if(a.indexOf(s.byday[c])<0)throw"Recurrence rrule 'byday' values must include only the following: 'SU', 'MO', 'TU', 'WE', 'TH', 'FR', 'SA'"}}var g=new Date(l),d=new Date(u),f=new Date,S=("0000"+g.getFullYear().toString()).slice(-4),E=("00"+(g.getMonth()+1).toString()).slice(-2),v=("00"+g.getDate().toString()).slice(-2),y=("00"+g.getHours().toString()).slice(-2),A=("00"+g.getMinutes().toString()).slice(-2),T=("00"+g.getSeconds().toString()).slice(-2),b=("0000"+d.getFullYear().toString()).slice(-4),D=("00"+(d.getMonth()+1).toString()).slice(-2),N=("00"+d.getDate().toString()).slice(-2),h=("00"+d.getHours().toString()).slice(-2),I=("00"+d.getMinutes().toString()).slice(-2),R=("00"+d.getMinutes().toString()).slice(-2),M=("0000"+f.getFullYear().toString()).slice(-4),w=("00"+(f.getMonth()+1).toString()).slice(-2),L=("00"+f.getDate().toString()).slice(-2),O=("00"+f.getHours().toString()).slice(-2),p=("00"+f.getMinutes().toString()).slice(-2),Y=("00"+f.getMinutes().toString()).slice(-2),U="",V="";y+A+T+h+I+R!=0&&(U="T"+y+A+T,V="T"+h+I+R);var B,C=S+E+v+U,j=b+D+N+V,m=M+w+L+("T"+O+p+Y);if(s)if(s.rrule)B=s.rrule;else{if(B="rrule:FREQ="+s.freq,s.until){var x=new Date(Date.parse(s.until)).toISOString();B+=";UNTIL="+x.substring(0,x.length-13).replace(/[-]/g,"")+"000000Z"}s.interval&&(B+=";INTERVAL="+s.interval),s.count&&(B+=";COUNT="+s.count),s.byday&&s.byday.length>0&&(B+=";BYDAY="+s.byday.join(","))}(new Date).toISOString();var H=["BEGIN:VEVENT","UID:"+n.length+"@"+e,"CLASS:PUBLIC","DESCRIPTION:"+i,"DTSTAMP;VALUE=DATE-TIME:"+m,"DTSTART;VALUE=DATE-TIME:"+C,"DTEND;VALUE=DATE-TIME:"+j,"LOCATION:"+o,"SUMMARY;LANGUAGE=en-us:"+t,"TRANSP:TRANSPARENT","END:VEVENT"];return B&&H.splice(4,0,B),H=H.join(r),n.push(H),H},download:function(e,t){if(n.length<1)return!1;t=void 0!==t?t:".ics",e=void 0!==e?e:"calendar";var a,l=i+r+n.join(r)+o;if(-1===navigator.userAgent.indexOf("MSIE 10"))a=new Blob([l]);else{var u=new BlobBuilder;u.append(l),a=u.getBlob("text/x-vCalendar;charset="+document.characterSet)}return saveAs(a,e+t),l},build:function(){return!(n.length<1)&&i+r+n.join(r)+o}}}console.log("Unsupported Browser")}};


function GenerateICS(title, description, start, end) {
    let cal = new ics();
    cal.addEvent(decodeURIComponent(title), decodeURIComponent(description), "", start, end);
    cal.download(decodeURIComponent(title));
}
</script><script>
    /* https://stackoverflow.com/a/26633844/3019650 */
    if (!window.CSS || !CSS.supports('color', 'var(--fake-var)')) {
        (function(a, b, c, d) {
            a = 'https://cdn.jsdelivr.net/npm/css-vars-ponyfill@2';
            b = document;
            c = 'script';
            d = b.createElement(c);
            d.src = a;
            d.type = 'text/java' + c;
            d.async = true;
            a = b.getElementsByTagName(c)[0];
            a.parentNode.insertBefore(d, a);
        })();

        function deferCssVars(method) {
            if (typeof cssVars === "function") {
                method();
            } else {
                setTimeout(function() {
                    deferCssVars(method)
                }, 50);
            }
        }
        deferCssVars(function() {
            cssVars()
        });
    }
</script>
</body>


<!-- Mirrored from www.merck.com/news/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have-been-supplied-to-the-u-s-government-for-use-in-the-united-states/ by HTTrack Website Copier/3.x [XR&CO'2014], Tue, 04 Oct 2022 17:10:52 GMT -->
</html>
